VQI注册研究:间歇性跛行干预患者吸烟率高达44%且存在地区差异
该研究利用VQI三个注册数据库2010-2015年数据,纳入37,632例因间歇性跛行接受血运重建的患者,发现干预时44%为活跃吸烟者且地区差异大(16-53%)。活跃吸烟与年龄<70岁、男性、COPD、无既往心血管手术、用药依从性差、ABI<0.9及髂上病变相关;手术方式与吸烟状态无关。随访中36%患者戒烟,年龄≥70岁及开放手术者更易戒烟。
要点
- 间歇性跛行血运重建患者中44%为活跃吸烟者,地区差异16-53%。
- 年轻、COPD、低ABI及髂上病变者吸烟率更高。
- 血运重建方式(PVI vs 旁路)不受吸烟状态影响。
核心结论
- VQI中因间歇性跛行接受干预的患者干预时44%为活跃吸烟者,地区差异显著。
- 活跃吸烟与年轻、合并症少、低ABI及髂上病变相关,与手术方式无关。
- 老年及开放手术患者随访期间更易戒烟。
研究设计与样本
- 回顾性队列研究,查询VQI infra-inguinal bypass、supra-inguinal bypass及PVI三个注册数据库。
- 2010-2015年共101,055例手术,其中40,269例(40%)针对间歇性跛行,37,632例数据完整纳入分析。
- 采用单变量及协变量分析评估患者因素、手术类型及病变水平与吸烟状态的关联。
主要发现
- 干预时活跃吸烟者占44%,地区质量组间变异范围16-53%。
- 活跃吸烟相关因素:年龄<70岁(PR 2.42)、男性(PR 1.03)、COPD(PR 1.35)、无既往心血管手术(PR 1.15)、用药依从性差(PR 1.10)、术前ABI<0.9(PR 1.19)、髂上病变(PR 1.14)。
- 手术方式(PVI vs 旁路)与吸烟状态无显著关联。
- 随访期间36%患者戒烟;戒烟预测因素包括年龄≥70岁(RR 1.45)、ABI≥0.9(RR 1.12)及旁路手术(RR 1.22)。
关键数值与推荐
- SVS间歇性跛行药物治疗指南对戒烟给出GRADE 1A推荐。
临床怎么用
- 间歇性跛行血运重建前应加强戒烟干预,尤其针对年轻、低ABI及髂上病变患者。
- 老年及开放手术患者随访中戒烟率较高,可针对性强化戒烟支持。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Society for Vascular Surgery practice guidelines for the medical treatment of intermittent claudication give a GRADE 1A recommendation for smoking cessation. Active smoking is therefore expected to be low in patients suffering from intermittent claudication selected for vascular surgical intervention. The aim of this study is to evaluate the prevalence of smoking in patients undergoing intervention for intermittent claudication at the national level and to determine the relationship between smoking status and intervention. METHODS: The Vascular Quality Initiative (VQI) registries for infra-inguinal bypass, supra-inguinal bypass, and peripheral vascular intervention (PVI) were queried to identify patients who underwent invasive treatment for intermittent claudication. Patient factors, procedure type (bypass versus PVI), and level of disease (supra-inguinal versus infra-inguinal) were evaluated for associations with smoking status (active smoking or nonsmoking) by univariate and covariate analysis. RESULTS: Between 2010 and 2015, 101,055 procedures were entered in the 3 registries, with 40,269 (40%) performed for intermittent claudication. Complete data for analysis were present in 37,632 cases. At the time of intervention, 44% of patients were active smokers, with wide variation by regional quality group (16-53%). In covariate analysis, active smoking at treatment was associated with age <70 years (prevalence ratio [PR] 2.42), male gender (PR 1.03), chronic obstructive pulmonary disease (PR 1.35), absence of prior cardiovascular procedures (PR 1.15), poor medication usage (PR 1.10), preoperative ankle-brachial index (ABI) <0.9 (PR 1.19), and supra-inguinal disease (PR 1.14). Invasiveness of treatment (PVI versus bypass procedures) was not significantly associated with smoking status. During follow-up, 36% of patients had quit smoking. Predictors of smoking cessation included age ≥70 years (RR 1.45), ABI ≥0.9 (RR 1.12), and bypass procedures (RR 1.22). CONCLUSIONS: At the time of treatment, 44% of patients undergoing intervention for intermittent claudication in the VQI were active smokers and there was a wide regional variation. Prevalence of active smoking was greater in the presence of younger age, fewer comorbidities, lower ABI, and supra-inguinal disease. Type of procedure performed, and in turn level of invasiveness required, did not appear to be influenced by smoking status. Elderly patients and those undergoing open procedures were more likely to quit smoking during follow up. These findings suggest opportunities for greater smoking cessation efforts before invasive therapies for intermittent claudication.
引用
- Gabel J, Jabo B, Patel S, et al. Smoking Habits of Patients Undergoing Treatment for Intermittent Claudication in the Vascular Quality Initiative. Ann Vasc Surg. 2017. PMID: 28522329. doi:10.1016/j.avsg.2017.04.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。